ArticleOphthalmology science2026
Two-Year Changes in Astigmatism in Myopic Children Wearing Lenslet-ARray-Integrated Spectacle Lenses.
Article in Ophthalmology science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To investigate the effects of Lenslet-ARray-Integrated (LARI) spectacle lenses on refractive and corneal astigmatism in myopic children. Design: A secondary analysis of data from a randomized, double-masked trial. Participants: Pertinent data were retrieved from the files of 209 participants from the previous 2-phase LARI study, which reported the efficacy of LARI lenses on myopia control in children aged 6 to 12 years. Methods: Data from participants of the LARI study (phase I: wearing LARI lenses or single-vision (SV) lenses for 12 months; phase II: all wore LARI lenses for another 12 months) were retrieved and analyzed. Participants who wore LARI lenses for 2 years were categorized as the LARI group, whereas those who switched from SV to LARI lenses were categorized as the SV lens switched over to LARI lens in the second year (SV-LARI) group. Data retrieved included cycloplegic spherical equivalent refraction and refractive astigmatism, axial length, and corneal astigmatism at 6-month intervals, and the vector components (J0 and J45) of refractive and corneal astigmatism were calculated for analysis. Main Outcome Measures: Changes in refractive and corneal astigmatism, J0, and J45. Results: No significant differences were found in increased refractive astigmatism, refractive J0 and J45, corneal astigmatism, and corneal J0 and J45 (all Conclusions: Wearing LARI lenses for 2 years did not seem to lead to any clinically significant additional progression in refractive and corneal astigmatism. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.